Frontlight ResearchEarly access
Trial site
Lublin
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Phase
- Phase 32 trials
- Status
- Active, not recruiting1 trial
- Enrolling by invitation1 trial
- Lead sponsor
- Sanofi2 trials
Running trials
Enrolling by invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
Active, not recruiting
SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Site data: ClinicalTrials.govUpdated 12 Nov 2026